for the three months ended
|
|
for the six months ended
|
||||||
| In 000€ | 2023 |
|
2022 |
|
2023 |
|
2022 |
|
| Net profit (loss) for the period | (494) |
896 |
3,221 |
1,023 |
||||
| Income taxes | 532 |
600 |
1,249 |
898 |
||||
| Financial cost | 670 |
1,320 |
2,045 |
2,561 |
||||
| Financial income | (1,305) |
(3,901) |
(2,114) |
(5,517) |
||||
| Operating (loss) profit | (597) |
(1,084) |
4,402 |
(1,036) |
||||
| Depreciation and amortization | 5,353 |
5,374 |
10,664 |
10,816 |
||||
| Corporate research and development | 737 |
816 |
1,459 |
1,465 |
||||
| Corporate headquarter costs | 2,576 |
2,104 |
5,238 |
4,612 |
||||
| Other operating income (expense) | (705) |
(640) |
(1,412) |
(1,211) |
||||
| Segment adjusted EBITDA | 7,364 |
6,568 |
20,350 |
14,647 |
||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20230724765653/en/
Contact:
Investor Relations
Harriet Fried
LHA
212.838.3777
hfried@lhai.com
